Clinical Trials

Rectal Cancer

At Lehigh Valley Health Network, we are committed to providing our patients and community with the best possible care and treatments. Our research scientists are integrated with our clinical departments for a comprehensive, collaborative approach to research. Have a question about clinical trials? Contact the Network Office of Research and Innovation at 610-402-9543.

Showing 3 of 3 Clinical Trials Related to Rectal Cancer

Clinical Research Trial

Amgen 757 Lung Cancer

A Phase 3, Randomized, Double-blind, Placebo-controlled, Multicenter Study of Tarlatamab Therapy in Subjects With Limited-Stage Small-Cell Lung Cancer (LS-SCLC) who Have not Progressed Following Concurrent Chemoradiation Therapy (DeLLphi-306)

Doctor(s) Running This Study
Suresh G. Nair, MD
Nicholas E. Lamparella, DO
M. Bijoy Thomas, MD
Jeffrey T. Brodsky, MD
Brian J. Patson, MD
Maged F. Khalil, MD
Bradley W. Lash, MD
Jeanette M. Blauth, MD
Lori A. Alfonse, DO
Simi Masand Rai, MD
Don J. Park, MD, PHD
Muhammad A. Rizvi, MD
Hasan H. Danish, MD
Heiwon Chung Whang, MD
Eliot L. Friedman, MD
Tara Morrison, MD
Paul Palyca, MD
Alyson F. McIntosh, MD, MPHIL
Aaron U. Blackham, MD
Clinical Research Trial

NRG-GI008

NRG-GI008 COLON ADJUVANT CHEMOTHERAPY BASED ON EVALUATION OF RESIDUAL DISEASE

Doctor(s) Running This Study
Maged F. Khalil, MD
Clinical Research Trial

A022104 Rectal Cancer

Testing the Addition of an Anti-Cancer Drug, Irinotecan, to the Standard Chemotherapy Treatment (FOLFOX) After Long-Course Radiation Therapy for Advanced-Stage Rectal Cancers to Improve the Rate of Complete Response and

Doctor(s) Running This Study
Maged F. Khalil, MD